// Imugene Announces Presentation on HER-Vaxx Cancer Vaccine at the American Association for Cancer Research 2019 Annual Meeting - Finance News Network Skip to main content

The Best Doctors in San Antonio

Image
oscar virtual primary care :: Article Creator Oscar To Offer Free Virtual Primary Care Visits - Becker's Hospital ... The free virtual primary care benefit includes unlimited virtual visits with Oscar primary care providers, and will be offered to members with individual and family plans. Oscar Primary Care will also offer some members $0 at-home vital monitors and in-home lab draws when ordered by an Oscar primary care provider.  The virtual primary care benefit will be launched in 10 markets across Florida, Texas, California, Colorado and New York, pending regulatory approval. In addition, Oscar will expand to 19 states and 47 markets in 2021. This includes four new states — Arkansas, North Carolina, Oklahoma and Iowa — plus 19 new markets. Read more here. More articles on payers:Anthem agrees to pay $27K medical bill after TV report airsLeapfrog Group: Employers rank Cigna highest, UnitedHealthcare lowest on drive for valueAnthem doub...

Imugene Announces Presentation on HER-Vaxx Cancer Vaccine at the American Association for Cancer Research 2019 Annual Meeting - Finance News Network

Media ReleasesImugene Limited

SYDNEY, Australia, 28 February 2019: Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, today announced Professor Ursula Wiedermann will present on the HER-Vaxx cancer vaccine at the American Association for Cancer Research (AACR) 2019 Annual Meeting.

The poster (abstract number 8249) will be presented by Prof Wiedermann, the co-inventor of the HER-Vaxx cancer vaccine and member of the Company’s Scientific Advisory Board, at the AACR Annual Meeting in Atlanta, Georgia scheduled for March 29 to April 3, 2019.

The abstract presentation is entitled ‘A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced cancer of the stomach.’

For further information please download PDF attached: Download this document



https://ift.tt/2C6RYzt

Comments

Popular posts from this blog

180+ chief medical officers to know | 2025

Primary Care - North Greece Internal Medicine & Pediatrics

Screening and Testing for Hepatitis B Virus Infection ...